Sun Yat-sen University Cancer Center and The University of Texas MD Anderson Cancer Center
5th Biennial Pathology Symposium of M. D. Anderson Cancer Center - Chinese Sister Institutions
Pathology of the 21st Century: From Molecular Diagnostics to Personalized Cancer Therapy
Program Directors: Jingping Yun, Jianyong Shao, Aysequl Sahin, Dongfeng Tan, and Jinsong Liu
Organizing Committee: Bogdan Czeriniak, Michael Deavers, Greg Fuller, Jinsong Liu, TJ, Liu, Aysequl Sahin, Jianyong Shao, Dongfeng Tan, Dan Xie, and Jingping Yun
We are pleased to invite you to Pathology of the 21st Century: From Molecular Diagnostics to Personalized Cancer Therapy, which will be held from May 31 to June 2, 2013, in Guangzhou, China. This symposium is jointly sponsored and organized by Sun Yat-sen University Cancer Center and The University of Texas MD Anderson Cancer Center.
The Biennial Pathology Symposium of M. D. Anderson Cancer Center-Chinese Sister Institutions was first held in partnership with MD Anderson’s sister institute, Fudan University Shanghai Cancer Center in Shanghai in 2005. Pathology of the 21st Century (P21) is an international program at MD Anderson that has been held six times, in the United States and elsewhere. P21 emphasizes the use of innovative diagnostic tools for neoplastic disorders and new neoplastic entities and classification systems. As one of MD Anderson’s sister institutes in China, Sun Yat-sen University Cancer Center is honored to host this year’s combined biennial pathology symposium and P21 conference in China.
The main theme of this conference is novel approaches to the pathological diagnosis and classification of tumors. The conference topics will cover a wide spectrum of neoplastic diseases, such as gynecological tumors, gliomas, thyroid neoplasia, melanocytic lesions, neuroendocrine tumors, colorectal cancer, and prostate cancer. Particular attention will be given to molecular and cytogenetic testing in pathological diagnosis and personalized therapy. Relevant topics, such as the application of and approach to immunohistochemical analyses in tumor pathology and the training of pathologists in the 21st century, will also be presented.
Professor Yi-Xin Zeng, president of Sun Yat-sen University Cancer Center, and Professor Ronald A. DePinho, president of MD Anderson, will be the chairpersons of this meeting. Thirteen leading pathologists from MD Anderson and several renowned Chinese pathologists will present lectures and interact with attendees. This conference will offer a great platform for exploring the development of pathology in the 21st century.
We look forward to your participation and hope you enjoy your time in Guangzhou.
Prof. Jing-Ping Yun Prof. Jian-Yong Shao
Director, Department of Pathology Director, Department of Molecular Diagnostics